Nitto Denko Corp.TSE: 6988

Financial Summary FY2025

· MarketScreener


Date: April 27, 2026

Preliminary

Summary of Consolidated Financial Statements for the Year Ended March 31, 2026 (IFRS Basis)

Listed company name: Nitto Denko Corporation

Stock exchange listing: Tokyo Stock Exchange, Prime Market

Code Number: 6988 URL https://www.nitto.com/ Company Representative: Tatsuya Akagi, President

Contact Person: Yasuhiro Iseyama, Senior Executive Vice President, Director of Corporate Accounting & Finance Division Phone: +81-6-7632-2101

Date of the general shareholders' meeting June 19, 2026 Estimated starting date of dividend paying June 22, 2026 Filing date of financial statements June 17, 2026 Preparation of supplementary explanatory materials: Yes

Holding of quarterly earnings release conference: Yes (for investment analysts and institutional investors)

(All monetary values noted herein are rounded down to the nearest million yen)

  1. Consolidated financial results for the year ended March 31, 2026

    1. Operating results (% of change from same period in the previous year)

      Revenue

      Operating profit

      Profit before income taxes

      Net profit

      Net profit attributable to owners of the

      parent company

      Total comprehensive income

      For the year ended March 31, 2026 For the year ended March 31, 2025

      Millions

      of yen

      %

      Millions

      of yen

      %

      Millions

      of yen

      %

      Millions

      of yen

      %

      Millions

      of yen

      %

      Millions

      of yen

      %

      1,028,171

      1,013,878

      1.4

      10.8

      183,615

      185,667

      (1.1)

      33.4

      184,976

      185,329

      (0.2)

      33.4

      133,537

      137,307

      (2.7)

      33.6

      133,498

      137,237

      (2.7)

      33.7

      203,629

      132,869

      53.3

      (19.4)

      Basic earnings per share

      Diluted earnings per share

      Return on equity attributable to owners of the parent company

      Net profit to total assets

      Operating profit to revenue

      For the year ended March 31, 2026 For the year ended March 31, 2025

      Yen

      Yen

      %

      %

      %

      197.20

      195.74

      197.11

      195.65

      12.2

      13.5

      13.4

      14.4

      17.9

      18.3

      (Reference) Share of profit of investments accounted for using the equity method:

      (For the year ended March 31, 2026) 147 million yen (For the year ended March 31, 2025) (108) million yen

      (Note) The Company has implemented the stock split with an effective date of October 1, 2024 and a record date of September 30, 2024. Each share of common stock has been split into five shares. The above basic and diluted earnings per share for the year ended March 31, 2025 and 2026 are based on the assumption that the stock split is conducted at the beginning of the fiscal year ended March 31, 2025.

    2. Financial position

      Total assets

      Total equity

      Equity attributable to owners of the parent company

      Ratio of equity attributable to owners of the parent company to total assets

      Equity attributable to owners of the parent company per share

      As of the year ended March 31, 2026

      As of the year ended

      March 31, 2025

      Millions of yen

      Millions of yen

      Millions of yen

      %

      Yen

      1,441,757

      1,321,920

      1,149,103

      1,045,114

      1,148,027

      1,044,083

      79.6

      79.0

      1,704.17

      1,502.42

      (Note) The Company has implemented the stock split with an effective date of October 1, 2024 and a record date of September 30, 2024. Each share of common stock has been split into five shares. The above equity attributable to owners of the parent company per share for the year ended March 31, 2025 and 2026 are based on the assumption that the stock split is conducted at the beginning of the fiscal year ended March 31, 2025.

    3. Cash flows

      Cash flows from operating activities

      Cash flows from investing activities

      Cash flows from financing activities

      Cash and cash equivalents

      at the end of period

      For the year ended March 31, 2026 For the year ended March 31, 2025

      Millions of yen

      Millions of yen

      Millions of yen

      Millions of yen

      192,183

      217,908

      (107,436)

      (115,105)

      (106,597)

      (78,890)

      359,805

      363,344

  2. Dividends

    Dividends per share

    Dividends total (Annual)

    Dividend payout ratio (Consolidated)

    Dividends to equity attributable to owners of the parent company

    (Consolidated)

    1Q

    2Q

    3Q

    Year-end

    Annual

    March, 2025

    March, 2026

    Yen

    -

    -

    Yen 140.00

    30.00

    Yen

    -

    -

    Yen 28.00

    30.00

    Yen

    -60.00

    Millions of yen

    39,110

    40,419

    % 28.6

    30.4

    % 3.9

    3.7

    (Forecast)

    March, 2027

    -

    32.00

    -

    32.00

    64.00

    30.6

    (Note) The Company has implemented the stock split with an effective date of October 1, 2024 and a record date of September 30, 2024. Each share of common stock has been split into five shares. The above year-end dividend per share for the fiscal year ended March 31, 2025 is based on a number of shares taking into account the stock split. The total annual dividend per share for the fiscal year ended March 31, 2025 is not presented because the total of the interim dividend and the year-end dividend cannot be calculated due to effect of the stock split. With taking the stock split into account, the interim dividend per share for the fiscal year ended March 31, 2025 would be 28 yen and the total annual dividend per share for the fiscal year ended March 31, 2025 would be 56 yen.

  3. Forecast for the fiscal year ending March 31, 2027

(% of change from same period in the previous year)

Revenue

Operating

profit

Profit before income taxes

Net profit

Net profit attributable to owners of the parent company

Basic earnings per share

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

First half

527,500

2.7

97,000

2.6

97,000

1.9

71,000

3.0

71,000

3.0

105.39

Annual

1,065,000

3.6

193,000

5.1

193,000

4.3

141,000

5.6

141,000

5.6

209.30

  • Others

    1. Changes in significant subsidiaries during this fiscal year: No

    2. Changes in accounting policies applied and changes in accounting estimates

      1. Changes in accounting policies required by IFRS: No

      2. Changes in accounting policies other than the above: No

      3. Changes in accounting estimates: No

    3. Number of issued shares (Common stock)

      1. Number of issued shares at the end of the period (including treasury shares)

        As of March 31, 2026: 678,659,700 As of March 31, 2025: 706,760,750

      2. Number of treasury shares at the end of the period

        As of March 31, 2026: 4,999,950 As of March 31, 2025: 11,826,050

      3. Average number of issued shares during the period (cumulative from the beginning of the period)

For the year ended March 31, 2026: 676,979,122 For the year ended March 31, 2025: 701,124,380

(Note) The Company has implemented the stock split with an effective date of October 1, 2024 and a record date of September 30, 2024. Each share of common stock has been split into five shares. The above "Number of issued shares at the end of the period", "Number of treasury shares at the end of the period" and "Average number of issued shares during the period" are based on the assumption that the stock split is conducted at the beginning of the fiscal year ended March 31, 2025.

(Reference) Non-consolidated financial results for the year ended March 31, 2026

  1. Operating results (% of change from previous year)

    Net sales

    Operating profit

    Ordinary profit

    Net profit

    For the year ended March 31, 2026 For the year ended March 31, 2025

    Millions of yen

    %

    Millions of yen

    %

    Millions of yen

    %

    Millions of yen

    %

    576,097

    598,416

    (3.7)

    15.4

    106,522

    122,014

    (12.7)

    38.0

    125,083

    131,046

    (4.6)

    39.0

    95,589

    94,998

    0.6

    26.9

    Net profit per share

    - Basic

    Net profit per share

    - Diluted

    Yen

    Yen

    For the year ended

    March 31, 2026

    141.20

    141.14

    For the year ended

    March 31, 2025

    135.50

    135.44

    (Note) The Company has implemented the stock split with an effective date of October 1, 2024 and a record date of September 30, 2024. Each share of common stock has been split into five shares. The above basic and diluted net profit per share are based on the assumption that the stock split is conducted at the beginning of the fiscal year ended March 31, 2025.

  2. Financial position

    Total assets

    Net assets

    Ratio of shareholder's equity to total assets

    Net assets per share

    Millions of yen

    Millions of yen

    %

    Yen

    As of the year ended

    March 31, 2026

    840,085

    533,980

    63.5

    792.22

    As of the year ended

    March 31, 2025

    824,328

    537,478

    65.2

    773.00

    (Reference) Shareholders' equity: (March 31, 2026) 533,687 million yen (March 31, 2025) 537,185 million yen

    (Note) The Company has implemented the stock split with an effective date of October 1, 2024 and a record date of September 30, 2024. Each share of common stock has been split into five shares. The above net assets per share is based on the assumption that the stock split is conducted at the beginning of the fiscal year ended March 31, 2025.

    • This summary is not subject to audit procedures by Certified Public Accountants or audit firm.

    • Explanations for adequate utilization of the forecast and other special matters

The forward-looking statements shown in this report, including the forecast, are prepared based on information available to the Company and on certain assumptions deemed reasonable as of the issuing date of the report. Consequently, the statements herein do not constitute promises regarding actual results by the Company. Actual results may differ materially from forecasted figures due to various unknown factors.

(Reference) Segment Information (Millions of yen)

For the year ended March 31, 2025

For the year ended March 31, 2026

Industrial Tape

Optronics

Human Life

Others Adjustment

Total

Revenue Revenue Y-o-Y (%)

Revenue 351,829 366,607 104.2

Operating profit 45,864 51,662 112.6

Information Fine Materials 407,654 386,234 94.7

Circuits Materials 134,339 141,577 105.4

Total 541,993 527,812 97.4

Operating profit 173,117 149,871 86.6

Life Science 44,529 54,011 121.3

Membrane 34,671 33,409 96.4

Personal Care Materials 53,211 56,280 105.8

Total 132,411 143,702 108.5

Operating profit (11,718) (5,041) -

Revenue 19 11 59.4

Operating profit (12,229) (6,971) -

Revenue (12,376) (9,961) -

Operating profit (9,365) (5,905) -

Revenue 1,013,878 1,028,171 101.4

Operating profit 185,667 183,615 98.9

(Note) As a result of changes in the management structure for the year ended March 31, 2026, some changes have been made to reporting segments. Such changes have been reflected in the figures for the year ended March 31, 2025.

  1. Consolidated Financial Statements

    1. Consolidated statement of financial position

      (Millions of yen)

      As of the year ended March 31, 2025

      As of the year ended March 31, 2026

      Assets

      Current assets

      Cash and cash equivalents

      363,344

      359,805

      Trade and other receivables

      210,418

      231,880

      Inventories

      142,932

      157,870

      Other financial assets

      7,732

      19,436

      Other current assets

      25,781

      28,301

      Total current assets

      750,209

      797,294

      Noncurrent assets

      Property, plant and equipment

      417,636

      466,960

      Right-of-use assets

      19,058

      20,608

      Goodwill

      57,167

      64,125

      Intangible assets

      17,026

      16,942

      Investments accounted for using equity method

      7,319

      6,687

      Financial assets

      11,096

      13,516

      Deferred tax assets

      17,873

      19,095

      Other noncurrent assets

      24,533

      36,526

      Total noncurrent assets

      571,711

      644,463

      Total assets

      1,321,920

      1,441,757

      (Millions of yen)

      As of the year ended March 31, 2025

      As of the year ended March 31, 2026

      Liabilities and equity Liabilities

      Current liabilities

      Trade and other payables

      100,508

      103,605

      Borrowings

      455

      -

      Income tax payables

      28,183

      17,932

      Other financial liabilities

      36,102

      39,828

      Other current liabilities

      56,485

      64,604

      Total current liabilities

      221,735

      225,970

      Noncurrent liabilities

      Other financial liabilities

      20,160

      21,711

      Defined benefit liabilities

      28,991

      29,809

      Deferred tax liabilities

      3,856

      11,780

      Other noncurrent liabilities

      2,062

      3,381

      Total noncurrent liabilities

      55,070

      66,683

      Total liabilities

      276,806

      292,653

      Equity

      Equity attributable to owners of the parent company

      Share capital

      26,783

      26,783

      Capital surplus

      49,934

      49,934

      Retained earnings

      890,040

      912,008

      Treasury shares

      (31,799)

      (13,849)

      Other components of equity

      109,124

      173,150

      Total equity attributable to owners of the parent

      company

      1,044,083

      1,148,027

      Noncontrolling interests

      1,031

      1,075

      Total equity

      1,045,114

      1,149,103

      Total liabilities and equity

      1,321,920

      1,441,757

    2. Consolidated statement of profit or loss and consolidated statement of comprehensive income (Consolidated statement of profit or loss)

      (Millions of yen)

      For the year ended For the year ended

      March 31, 2025

      March 31, 2026

      Revenue

      1,013,878

      1,028,171

      Cost of sales

      618,365

      637,408

      Gross profit

      395,513

      390,763

      Selling, general and administrative expenses

      151,835

      156,322

      Research and development expenses

      46,771

      48,025

      Other income

      11,827

      12,571

      Other expenses

      23,066

      15,371

      Operating profit

      185,667

      183,615

      Finance income

      2,901

      3,258

      Finance expenses

      3,131

      2,045

      Share of profit of investments accounted for using the equity method

      (108)

      147

      Profit before income taxes

      185,329

      184,976

      Income tax expenses

      48,021

      51,438

      Net profit

      137,307

      133,537

      Net profit attributable to:

      Owners of the parent company

      137,237

      133,498

      Noncontrolling interests

      70

      38

      Total

      137,307

      133,537

      Earnings per share attributable to owners of the parent company

      Basic earnings per share (Yen)

      195.74

      197.20

      Diluted earnings per share (Yen)

      195.65

      197.11

      (Consolidated statement of comprehensive income)

      (Millions of yen)

      For the year ended March 31, 2025

      For the year ended March 31, 2026

      Net profit 137,307 133,537

      Other comprehensive income

      Items that will not be reclassified to profit or loss

      Net changes on financial assets measured at fair value

      through other comprehensive income

      (12) 103

      Remeasurement of defined benefit liability 9,066 5,963 Items that may be reclassified to profit or loss

      Exchange differences on translation of foreign

      operations

      (13,453) 63,723

      Net changes in fair value of cash flow hedges 0 (0) Share of other comprehensive income of investments

      accounted for using equity method

      (39) 302

      Total other comprehensive income

      (4,438)

      70,092

      Total comprehensive income

      132,869

      203,629

      Total comprehensive income attributable to: Owners of the parent company

      132,783

      203,566

      Noncontrolling interests

      86

      63

      Total

      132,869

      203,629

    3. Consolidated statement of changes in equity For the year ended March 31, 2025

Equity attributable to owners of the parent company

(Millions of yen)

Share capital

Capital surplus

Retained earnings

Treasury shares

Other components

Total

Noncontrolling

Total equity

of equity

interests

Balance as of April 1, 2024

26,783

49,928

808,062

(23,298)

122,544

984,020

1,028

985,048

Net profit

-

-

137,237

-

-

137,237

70

137,307

Other comprehensive

income

-

-

-

-

(4,454)

(4,454)

15

(4,438)

Total comprehensive income

-

-

137,237

-

(4,454)

132,783

86

132,869

Share based remuneration transactions

-

-

-

-

123

123

-

123

Dividends

-

-

(38,040)

-

-

(38,040)

(20)

(38,060)

Changes in treasury

shares

-

(26,308)

-

(8,501)

-

(34,809)

-

(34,809)

Transfer from other components of equity

-

-

9,089

-

(9,089)

-

-

-

to retained earnings

Acquisition of NCI

without change in

-

6

-

-

-

6

(63)

(56)

control

Transfer from

retained earnings

to capital surplus

-

26,308

(26,308)

-

-

-

-

-

Total transactions with owners

-

6

(55,259)

(8,501)

(8,965)

(72,720)

(83)

(72,803)

Balance as of March 31, 2025

26,783

49,934

890,040

(31,799)

109,124

1,044,083

1,031

1,045,114

For the year ended March 31, 2026

Equity attributable to owners of the parent company

(Millions of yen)

Share capital

Capital surplus

Retained earnings

Treasury shares

Other components of equity

Total

Noncontrolling interests

Total equity

Balance as of April 1, 2025

26,783

49,934

890,040

(31,799)

109,124

1,044,083

1,031

1,045,114

Net profit

-

-

133,498

-

-

133,498

38

133,537

Other comprehensive income

-

-

-

-

70,067

70,067

24

70,092

Total comprehensive income

-

-

133,498

-

70,067

203,566

63

203,629

Share based

remuneration transactions

-

19

-

-

(88)

(69)

-

(69)

Dividends

-

-

(39,667)

-

-

(39,667)

(19)

(39,687)

Changes in treasury shares

-

(77,835)

-

17,950

-

(59,884)

-

(59,884)

Transfer from other components of equity

-

-

5,952

-

(5,952)

-

-

-

to retained earnings

Transfer from retained earnings

-

77,815

(77,815)

-

-

-

-

-

to capital surplus

Others

-

-

-

-

-

-

0

0

Total transactions with owners

-

0

(111,530)

17,950

(6,041)

(99,622)

(18)

(99,640)

Balance as of March 31, 2026

26,783

49,934

912,008

(13,849)

173,150

1,148,027

1,075

1,149,103

(4) Consolidated statement of cash flows

(Millions of yen)

For the year ended March 31, 2025

For the year ended March 31, 2026

Cash flows from operating activities

Profit before income taxes

185,329

184,976

Depreciation and amortization

65,595

70,677

Impairment losses

12,339

4,717

Increase (decrease) in defined benefit liabilities

1,048

(1,196)

Decrease (increase) in trade and other receivables

(3,791)

(4,670)

Decrease (increase) in inventories

(8,526)

(5,957)

Increase (decrease) in trade and other payables

2,369

332

Increase (decrease) in advances received

(413)

540

Interest and dividend income

2,849

3,214

Interest expenses paid

(809)

(1,036)

Income taxes (paid) refunded

(34,304)

(57,302)

Others

(3,779)

(2,111)

Net cash provided by (used in) operating activities

217,908

192,183

Cash flows from investing activities

Purchase of property, plant and equipment and intangible assets

(106,003) (96,607)

Proceeds from sale of property, plant and equipment

and intangible assets

Decrease (increase) in time deposits

208

(2,371)

4,534

(12,110)

Purchase of investment securities

(762)

(3,123)

Proceeds from sale of investment securities

55

8

Purchase of shares of subsidiaries and affiliates

(6,256)

(206)

Others

23

68

Net cash provided by (used in) investing activities

(115,105)

(107,436)

Cash flows from financing activities

Net increase (decrease) in short-term borrowing

109

-

Repayment of lease liabilities

(5,822)

(6,626)

Decrease (increase) in treasury shares

(35,062)

(60,287)

Cash dividends paid

(38,040)

(39,667)

Others

(75)

(15)

Net cash provided by (used in) financing activities

(78,890)

(106,597)

Effect of exchange rate changes on cash and cash

equivalents

(2,837)

18,311

Net increase (decrease) in cash and cash equivalents

21,074

(3,538)

Cash and cash equivalents at the beginning of the period

342,269

363,344

Cash and cash equivalents at the end of the period

363,344

359,805

(Segment information)

  1. Outline of reportable segments

    Reportable segments of the Group are determined as segments whose separate financial information is available among the constituent units of the Group and which are regularly used by the Board of Directors, the chief operating decision maker, to determine the allocation of management resources and to evaluate their business results.

    The Group has divisions by product, and each division develops comprehensive domestic and overseas strategies for its products and conducts business activities.

    The Group's segments are based on three product divisions, and its three reportable segments are the Industrial Tape segment, the Optronics segment and the Human Life segment. Each reportable segment is grouped into one operating segment based on similarities in products, markets, and other aspects.

    Operating segment

    Major products or business

    Industrial Tape

    Functional Base Products (bonding and joining products, protective materials,

    processing materials, automotive products, etc.)

    Optronics

    Information Fine Materials (optical films, etc.), Circuits Materials (CIS (Circuit Integrated

    Suspension), high-precision circuits, etc.)

    Human Life

    Life Science (oligonucleotide contract manufacturing business, nucleic acid synthesis materials, nucleic acid drug discovery, medical products, etc.), Membrane (high-polymer separation membrane), Personal Care Materials (functional film for hygienic materials,

    etc.)

    Others

    New Business, Other Products

    Intersegment revenue is based on prevailing market prices. Major products for each segment

  2. Information regarding revenue, profit or loss, assets, and other items by segments Segment information regarding the Group's reportable segments is as follows.

    For the year ended March 31, 2025

    Reportable segments

    (Millions of yen)

    Figures in

    Industrial Optronics Human Life Total Tape

    Others Total Adjustment

    consolidated statement of profit or loss

    Revenue from external

    customers

    348,960

    537,852

    125,570

    1,012,383

    19

    1,012,403

    1,475

    1,013,878

    Intersegment revenue

    2,869

    4,141

    6,841

    13,851

    -

    13,851

    (13,851)

    -

    Total segment revenue

    351,829

    541,993

    132,411

    1,026,234

    19

    1,026,254

    (12,376)

    1,013,878

    Operating profit (loss)

    45,864

    173,117

    (11,718)

    207,262

    (12,229)

    195,033

    (9,365)

    185,667

    Finance income

    2,901

    Finance expenses Share of profit of

    investments accounted for

    using the equity method

    (3,131)

    (108)

    Profit before income taxes

    185,329

    Segment assets Other items:

    301,496

    749,095

    229,308

    1,279,901

    9,719

    1,289,620

    32,299

    1,321,920

    Depreciation and

    amortization

    18,451

    27,263

    11,562

    57,277

    864

    58,141

    7,454

    65,595

    Impairment losses Increase in property, plant and equipment and

    885

    18,795

    2,016

    47,875

    4,042

    15,108

    6,945

    81,779

    5,211

    1,741

    12,156

    83,520

    183

    9,456

    12,339

    92,976

    intangible assets

    (Note) 1. Others is an operating segment that is not included in the reportable segments and consists of New Business.

    1. Adjustment of operating profit (loss) amounted to (9,365) million yen includes other incomes (losses) not allocated to each operating segment.

    2. Adjustment of segment assets amounted to 32,299 million yen includes Cash and cash equivalents, Property, plant and equipment and others not belonging to each operating segment.

    3. As a result of changes in the management structure for the year ended March 31, 2026, some changes have been made to reporting segments. Such changes have been reflected in the figures for the year ended March 31, 2025.

For the year ended March 31, 2026

Reportable segments

(Millions of yen) Figures in

Industrial Optronics Human Life Total Tape

Others Total Adjustment

consolidated statement of profit or loss

Revenue from external

customers

364,827

524,598

137,246

1,026,672

11

1,026,684

1,487

1,028,171

Intersegment revenue

1,780

3,213

6,455

11,448

-

11,448

(11,448)

-

Total segment revenue

366,607

527,812

143,702

1,038,121

11

1,038,132

(9,961)

1,028,171

Operating profit (loss)

51,662

149,871

(5,041)

196,492

(6,971)

189,521

(5,905)

183,615

Finance income

3,258

Finance expenses Share of profit of

investments accounted for

using the equity method

(2,045)

147

Profit before income taxes

184,976

Segment assets Other items:

343,802

831,110

241,639

1,416,552

10,645

1,427,198

14,559

1,441,757

Depreciation and

amortization

18,801

30,527

11,885

61,213

1,099

62,313

8,363

70,677

Impairment losses Increase in property, plant and equipment and

1,476

19,339

1,389

43,628

1,520

16,853

4,385

79,821

59

1,567

4,445

81,389

272

5,452

4,717

86,841

intangible assets

(Note) 1. Others is an operating segment that is not included in the reportable segments and consists of New Business.

  1. Adjustment of operating profit (loss) amounted to (5,905) million yen includes other incomes (losses) not allocated to each operating segment.

  2. Adjustment of segment assets amounted to 14,559 million yen includes Cash and cash equivalents, Property, plant and equipment and others not belonging to each operating segment.

-